DongKook Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
DongKook Pharmaceutical has a total shareholder equity of ₩604.2B and total debt of ₩72.7B, which brings its debt-to-equity ratio to 12%. Its total assets and total liabilities are ₩839.5B and ₩235.3B respectively. DongKook Pharmaceutical's EBIT is ₩66.9B making its interest coverage ratio 109.7. It has cash and short-term investments of ₩94.2B.
Key information
12.0%
Debt to equity ratio
₩72.71b
Debt
| Interest coverage ratio | 109.7x |
| Cash | ₩94.16b |
| Equity | ₩604.22b |
| Total liabilities | ₩235.32b |
| Total assets | ₩839.54b |
Recent financial health updates
We Think DongKook Pharmaceutical (KOSDAQ:086450) Can Stay On Top Of Its Debt
May 06
DongKook Pharmaceutical (KOSDAQ:086450) Seems To Use Debt Quite Sensibly
Feb 01Recent updates
We Think DongKook Pharmaceutical (KOSDAQ:086450) Can Stay On Top Of Its Debt
May 06DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 06How Much Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Do Insiders Own?
Mar 15The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Has Gained 136%, So Why Not Pay It Some Attention?
Feb 28DongKook Pharmaceutical Co., Ltd.'s (KOSDAQ:086450) Stock Is Going Strong: Is the Market Following Fundamentals?
Feb 14
DongKook Pharmaceutical (KOSDAQ:086450) Seems To Use Debt Quite Sensibly
Feb 01DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jan 19The Attractive Combination That Could Earn DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) A Place In Your Dividend Portfolio
Jan 06DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Dec 24With EPS Growth And More, DongKook Pharmaceutical (KOSDAQ:086450) Is Interesting
Dec 21What Kind Of Investors Own Most Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)?
Dec 08The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Is Up 177% And Shareholders Are Boasting About It
Nov 23Financial Position Analysis
Short Term Liabilities: A086450's short term assets (₩419.2B) exceed its short term liabilities (₩203.1B).
Long Term Liabilities: A086450's short term assets (₩419.2B) exceed its long term liabilities (₩32.2B).
Debt to Equity History and Analysis
Debt Level: A086450 has more cash than its total debt.
Reducing Debt: A086450's debt to equity ratio has reduced from 16.7% to 12% over the past 5 years.
Debt Coverage: A086450's debt is well covered by operating cash flow (57.5%).
Interest Coverage: A086450's interest payments on its debt are well covered by EBIT (109.7x coverage).